Marco Radi @marcoradi@qoto.org

#Introduction.
I am a Senior Scientist @UW focusing on T cell #immunology interested in what constitutes the most beneficial T cell response to infection. Also fascinated by the complexities and oddities of non-mammalian immune systems.

Something people don’t know about me: In rare moments of quiet, I sketch (see work-in-progress pic).

I am here to keep up-to-date with the latest in science news, publishing, and banter. Might connect with the #indie music scene for some tunes too.

First post an a short intro. I’m a medicinal chemist/drug discoverer in academia. My group works on a variety of areas: cancer and neuroscience mainly. For (permanent) fun, when my students discover an in vivo probe, it gets tattooed on me. Can’t wait for our #PROTAC project to be successful, may need my leg.

#Druginvestigation #IDMastodon This #ClinicalReview showcases covalent #Drugdiscovery milestones & Targeted covalent inhibitors with emphasis on the lessons learned from these programmes and how an evolving toolbox of covalent drug discovery techniques facilitates success in this field. @nature
https://www.nature.com/articles/s41573-022-00542-z?utm_source=nrd_etoc&utm_medium=email&utm_campaign=toc_41573_21_12&utm_content=20221129

We study pulmonary #immunity to #Tuberculosis and
#influenza. We used to focus on T cells but now it's pretty much any/everything We believe in #openscience (and love #biorxiv)

Hi everyone! I guess that it was about time, so this is my #introduction My name is Jordi, I'm Associate Professor at Uppsala University. I'm a screener, phenotypic drug discovery and automation are two of my professional passions. Otherwise you will find me playing with my kids, eating good food with the family, doing sports (Svensk Klassiker anyone?), and listening to music whenever time allows. See you around!

The error bars in Figure 9 are specTacular.

https://pubpeer.com/publications/47F57138B29B27649DB9D27D28837B

FDA approves most expensive drug ever, a $3.5 million-per-dose gene therapy for hemophilia B

https://www.cbsnews.com/news/fda-approves-hemgenix-most-expensive-drug-hemophilia-b/

Sure, but what's the copay?

#science #politics #pharma

We have an opportunity for an outstanding scientist to establish their research group at the Perutz. The successful candidate will be offered an #assistantprofessor position at the Medical University of Vienna. Read more: https://tinyurl.com/4hjm863y #sciencjobs #facultyjobs #academicjobs

#Introduction: I am curious about how proteins and membranes work in cells to deliver cargos. Multidisciplinary lab (with great collaborators) at UMass Chan Medical School #MembraneTraffic #Biochemistry #StructuralBiology #CryoEM #Biophysics #CellBiology #Genetics #Immunology
Also passionate to increase diversity, equity, inclusion and belonging in #Science #Academia.

By way of #introduction, (or #introductions), I'm a writer. I write a column on science for the New York Times, and I also write books. ( https://carlzimmer.com/books/ ) The pandemic has taken up a lot of my working attention since early 2020, but other aspects of biology have obsessed me in previous years, & I now have some time for them again. Neanderthals, aliens, CRISPR, ecological collapse, etc.

Still pondering how best to use Mastodon. (I haven't deleted my Twitter account, at least not yet.)

#introductions Hi all, I notice many familiar faces on this server so I decided to move in. About myself: #drugdiscovery, #antibodies #engineering, #biotech, #startup. Look forwards to exchanging ideas about science and technology. 🤝

Time for my #introduction I suppose.

Was a #pharmaceutical journalist covering #pharma #biotech, #healthcare and #digitalhealth.

Now research director at a #lifesciences digital strategy consultancy, writing about many of the same themes, but also business-orientated topics like #customerexperience (#CX), #digital transformation and commercial strategy.

May also post about #music (particularly #punk and #indie), #Bengali language/culture, #art and #books.

Merck to acquire Imago BioSciences in deal worth $1.35bn

https://www.pmlive.com/pharma_news/merck_to_acquire_imago_biosciences_in_deal_worth_$1.35bn_1481539

#pharma #biotech